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AbstrACt 
Objectives To assess the degree to which variations in 
publicly reported hospital scores arising from the English 
Cancer Patient Experience Survey (CPES) are subject to 
chance.
Design Secondary analysis of publically reported data.
setting English National Health Service hospitals.
Participants 72 756 patients who were recently treated 
for cancer in one of 146 hospitals and responded to the 
2016 English CPES.
Main outcome measures Spearman-Brown reliability 
of hospital scores on 51 evaluative questions regarding 
cancer care.
results Hospitals varied in respondent sample size with 
a median hospital sample size of 419 responses (range 
31–1972). There were some hospitals with generally 
highly reliable scores across most questions, whereas 
other hospitals had generally unreliable scores (the 
median reliability of question scores within individual 
hospitals varied between 0.11 and 0.86). Similarly, there 
were some questions with generally high reliability across 
most hospitals, whereas other questions had generally 
low reliability. Of the 7377 individual hospital scores 
publically reported (146 hospitals by 51 questions, minus 
69 suppressed scores), only 34% reached a reliability of 
0.7, the minimum generally considered to be useful. In 
order for 80% of the individual hospital scores to reach a 
reliability of 0.7, some hospitals would require a fourfold 
increase in number of respondents; although in a few 
other hospitals sample sizes could be reduced.
Conclusions The English Patient Experience Survey 
represents a globally unique source for understanding 
experience of a patient with cancer; but in its present 
form, it is not reliable for high stakes comparisons of the 
performance of different hospitals. Revised sampling 
strategies and survey questions could help increase the 
reliability of hospital scores, and thus make the survey fit 
for use in performance comparisons.
IntrODuCtIOn
‘Before you can improve it you first have to 
measure it’ is a common adage of the quality 
improvement movement across the world.1 
Coupled with a tendency towards greater 
public accountability, this maxim has led to 
an ever-increasing number of measurement 
initiatives, typically underpinned by public 
reporting of scores of healthcare organisa-
tions.2 3 
Together with patient safety and clinical 
effectiveness, patient experience is being 
increasingly accepted as a distinct dimen-
sion of care quality.4 Relatedly, policymakers 
regularly commission large-scale nationwide 
patient surveys in the USA and the UK.5–7 
Most such surveys are aimed at patients with 
a diverse range of conditions. However, a 
repeatable disease-specific survey for patients 
with cancer was launched in England in 2010, 
and its findings are reported publicly and 
used by healthcare improvement teams in 
constructing and evaluating action plans.
The statistical reliability of measures of 
care quality remains a concern, as often 
the sample sizes involved in organisational 
comparisons are small. Ideally, measurement 
initiatives should follow prior examination 
of the statistical properties of indicators, but 
this is rarely the case. Some previous UK work 
strengths and limitations of this study
 ► We make use of the actual data used in public re-
porting of a high-profile survey with a high response 
rate, allowing us to make direct inferences about the 
quality indicators under consideration.
 ► Mixed effects logistic regression models are used to 
effectively partition the observed variability in hospi-
tal scores into that which is due to chance and that 
which reflects true differences between hospitals.
 ► Our analysis considers three different contributing 
factors affecting the reliability of hospital scores 
which can give insight into designing potential im-
provement efforts.
 ► This study only considers the crude hospital scores 
and not those adjusted for patient case mix which 
have recently been reported. However, as we expect 
any such adjustment to result in lower reliabilities 
the conclusions of the study remain valid.
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has examined the reliability of indicators of stage at diag-
nosis, diagnostic activity, general practice patient experi-
ence and general practice high risk prescribing, on the 
whole providing cautionary findings indicating the risk 
of unreliability of organisational rankings.8–12 Similar 
approaches and findings have been reported from the 
USA and Dutch settings.13–19
These considerations highlight the need for examining 
the reliability of hospital scores for the Cancer Patient 
Experience Survey (CPES) and have motivated us to 
examine this question empirically in this study. Its aim was 
to provide a detailed profile of the statistical reliability 
(and therefore of the role of chance) in hospital scores 
derived from the CPES.
MethODs
Data were analysed relating to respondents to the 2016 
CPES. The (English) CPES 2016 survey questionnaire 
is the sixth iteration of the survey first undertaken in 
2010. It includes many evaluative questions covering the 
experience of diagnosis, diagnostic testing, shared deci-
sion-making, specialist nursing, inpatient care, anti-
cancer treatment (surgery, radiotherapy, chemotherapy), 
hospital discharge and care in the community, together 
with an item for overall satisfaction with care. Survey 
results are reported publicly for each English hospital to 
drive local quality improvements to assist commissioners 
and providers of cancer care and to inform the work of 
the various charities and stakeholder groups supporting 
patients with cancer. The survey was mailed to all adult 
patients (aged 16 and over) discharged from a National 
Health Service hospital after inpatient or a day case 
cancer-related treatment during April–June 2016 after 
vital status checks at survey mail out (between 3 and 5 
months after the sampling period).
Respondents comprised patients aged 16 years and 
olderwho were treated for cancer in English National 
Health Service (NHS) hospitals during April–June 2016. 
The patients had relevant International Classification 
of Diseases, Tenth Revision codes for cancer (C00-99 
excluding C44 and C84 and D05) and were not known 
to have died prior to the survey mail out. Questionnaires 
were sent by post and responses could be made by post, 
online or using a telephone translation service. Details 
of the survey and method of administration have been 
published previously.20 In this study, we make use of publi-
cally reported hospital level data.21
Survey questions have up to seven response options 
which are dichotomised for public reporting such that 
hospitals scores represent the percentage of patients 
reporting a positive experience for each question. Scores 
are produced for hospital trusts and Clinical Commis-
sioning Groups (CCG). Further details are given in the 
technical documentation.22
We calculated the Spearman-Brown (interunit) reli-
ability of each hospital score. This is equivalent to the 
proportion of variation in hospital-level mean scores 
(for a given hospital sample size) attributable to the true 
(underlying) variation between them. Following previous 
work, we estimated reliability by partitioning the observed 
variability in hospital scores into two components, vari-
ability between hospitals and variability within hospitals, 
using mixed effects logistic regression models.8 23 For 
each question, a random intercept model (with no fixed 
effects other than the constant) was used to estimate the 
between hospital variance on the log-odds scale. This 
variance is a measure of the true (underlying) variation 
which can be thought of as that which would be seen 
with very large sample sizes in each hospital, such that 
the influence of sampling variation would be minimal.8 23 
Since our scores are binary measures, the within-hospital 
variance also depends on the level of achievement at each 
hospital and can be described by the binomial distribu-
tion. In this context, for each question the reliability λ of 
hospital i is given by
 
 
λi =
σ2b
σ2b +
1
pi
(
1−pi
)
ni  
 (1)
where  σ
2
b   is the true (underlying) between-hospital vari-
ance on the log-odds scale,  pi   is the observed proportion 
of patients reporting a positive experience in hospital  i
 and  ni   is the sample size of hospital  i  . High stakes purposes 
have important consequences for an individual or organi-
sation (ie, when attached to a financial incentive, publicly 
reported league tables or an outcome measure in a 
research study) and therefore require high measure relia-
bility. Reliability can take values from 0 to 1. Values <0.70 
are considered to represent low reliability, whereas values 
≥0.90 represent high reliability, required for ‘high stake’ 
purposes; in-between values are considered to represent 
adequate reliability.
Where less than 21 responses were received for an indi-
vidual question for a hospital, results were not publicly 
reported. Of the 148 hospitals included in the survey, 
there were two hospitals with less than 21 responses for 
every question. We excluded these two hospitals from our 
analysis. However, there remained 69 suppressed scores 
(from 18 hospitals) in the publically reported data due 
to low numbers of respondents to certain questions appli-
cable to only some patients. These scores were excluded 
from the analysis.
We calculated reliability for every hospital score on 
each question (a total of 146 hospitals multiplied by 51 
questions=7446 individual scores, minus 69 suppressed 
scores=7377 individual scores).
Additionally, the model outputs were used to estimate 
the increase in sample size required for each hospital to 
reach a reliability of 0.7 for each question.8 23 We used R 
V.3.4.4 for all analyses.
Patient involvement
The CPES development and administration are supported 
by an advisory group which includes patient advocates. 
The present study forms part of a wider project funded by 
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MacMillan Cancer Support for which there is an advisory 
group with patient representative participation.
results
Overall, there were 72 756 respondents to the CPES in 
2016 (response rate 66%) who were treated at the 146 
hospitals included in our analysis. Our findings are 
displayed in three figures each comprising a grid of 
hospitals by questions. Hospitals are ordered according 
to the number of responders and questions are ordered 
according to the between-hospital variance. Hospitals 
varied in respondent sample size with a median of 419 
responses (range 31–1972). Due to different sections of 
the questionnaire corresponding to different care path-
ways, not all questions were applicable to all patients and 
so the number of respondents varied considerably for 
each of the 51 questions. The number of respondents 
answering individual questions varied between 15 968 
(22%) and 71 773 (99%) with a median of 52 786 (73%). 
The number of respondents for each question in each 
hospital is shown in figure 1 and online supplementary 
material table 1.
The percentage of patients reporting a positive experi-
ence was highly variable between questions and between 
hospitals (figure 2 and online supplementary material 
table 2). The median percentage of patients reporting 
positive experience across individual questions was 79% 
(range 29%–96%), while the corresponding median 
across individual hospitals was 75% (range 51%–82%).
 Figure 3 (and online supplementary material table 
3) shows the reliability of the score for each question at 
each hospital. There were some hospitals with generally 
high reliability across most questions, whereas others had 
generally low reliability across survey items. The median 
reliability of question scores within individual hospitals 
was 0.60 (range 0.11–0.86). Similarly there were some 
questions with generally high reliability whereas others 
had generally low reliability. The median reliability of 
hospital scores within individual questions was 0.58 
(range 0.21–0.93).
Given that reliability depends on the sample size, the 
between-hospital variance and the hospital performance, 
we can examine how these factors influence reliability. 
Hospitals which tended to have low reliability also had small 
sample sizes. Also questions with low reliability tended to be 
those where the between-hospital variance is low. However, 
there are some exceptions to this which can be seen as the 
horizontal lines composed mostly of red squares in figure 3. 
Figure 1 Sample sizes for each of the 146 hospitals included in the analysis by question (Cancer Patient Experience Survey 
2016). Each rectangle corresponds to a single hospital and question. Its colour indicates one of five sample size categories as 
shown on the legend. The exact values for each cell in this plot are provided in online supplementary material table 1.
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Some CPES questions are unreliable across all hospitals 
because they have, across all hospitals, a small number of 
respondents to that particular question. Examples include 
questions only applicable to patients treated by radio-
therapy (questions 44 and 45). In general, questions with 
small sample sizes relate to patients on a particular care 
pathway. Other examples of low reliability can be seen in 
questions for which hospitals performance is consistently 
high (questions 5 and 25).
Overall, the reliability of hospitals scores for the survey 
is low. Of the 7377 individual hospital-question pairs, only 
35% reached a reliability of 0.7, the minimum generally 
considered to be useful. As it is possible to improve reli-
ability by increasing the sample size for a given hospital, 
we calculated how many multiples of the current sample 
size would be required to reach a reliability of 0.7 for each 
question (figure 4). It would be possible for 60% of hospital 
scores to reach a reliability of 0.7 by doubling the individual 
hospital sample size. Further increases lead to smaller gains, 
though 80% of the individual hospital scores would have 
achieved a reliability of 0.7 or more with four times as much 
data (which represents the upper limit of what could be 
achieved within a single year of data collection, though 
could also be achieved by aggregating over longer time 
periods).
DIsCussIOn
In this study, we have profiled the reliability of a high-pro-
file national patient experience survey for patients 
with cancer. Our findings show that about two-thirds of 
hospital scores in this survey do not meet reliability levels 
generally accepted as useful. In practical terms, this means 
that identification of hospitals that are performing well 
in specific aspects of care is hampered due to the influ-
ence of chance. The lack of reliability can be attributed to 
different factors which have variable influence.
Although there are thousands of healthcare quality 
indicators in current use, most are bereft of any evalua-
tion of their statistical reliability. Patient experience scores 
of English general practices arising from early waves of 
the GPPS survey were found to have very high reliability, 
enabling subsequent reductions in the survey sample.9 10 
In contrast, the present study, examining the reliability 
of CPES hospital scores for the first time, suggests the 
need for increases in the survey samples (see below). The 
present study forms part of an emerging body of literature 
Figure 2 Proportions of patients reporting a positive experience by question and for each of the 146 hospitals included in 
the analysis (Cancer Patient Experience Survey 2016). Each rectangle corresponds to a single hospital and question. Its colour 
indicates one of five proportions categories as shown on the legend. The exact values for each cell in this plot are provided in 
the online supplementary material table 2.
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Figure 3 Main central grid: reliability of hospital scores for each of the 146 hospitals included in the analysis (Cancer Patient 
Experience Survey 2016). Each rectangle corresponds to a single hospital and question. Its colour indicates one of four 
reliability categories as shown on the legend. Left hand side plot: the variance for each question on the log odds scale. The 
order of the questions has the same order than that of the main grid and is sorted from the question with lowest between-
hospital variance to the question with greatest between-hospital variance. Bottom plot: the sample size for each hospital in 
terms of the total number of responders. The order of the hospitals has the same order than that of the main grid and is sorted 
from the hospital with the smallest sample size to the hospital with greatest sample size. The exact values for each cell in this 
plot are provided in the online supplementary material table 3.
Figure 4 The expected percentage of hospital scores reaching a reliability of at least 0.7 when changing individual hospital 
sample sizes for each question.
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examining the reliability of a diverse range of quality indi-
cators, including from the UK, the USA and The Nether-
lands8–19 22 23; we would nonetheless like to re-emphasise 
the mismatch between the very large number of indica-
tors in current use and the small number of indicators 
that have been profiled for their reliability.
The key strength of this study is the use of the actual 
data used in public reporting of a high-profile survey with 
a high response rate. Its main limitation is that our anal-
ysis does not take into account the influence of patient 
case mix. Certain patient groups have systematic tenden-
cies towards reporting positive experiences compared 
with others,24 25 and for this reason, the results of the 
survey are reported in both adjusted and unadjusted 
form. Nonetheless, as patient case mix explains some 
of the variability between hospitals,26 had we calculated 
the reliability of case-mix adjusted scores we would have 
found the reliability would have been even lower than 
that presented here.
There are some hospitals that have low reliability for 
most questions as they treat a small number of patients, 
meaning that the uncertainty on their scores is inherently 
high. Further, there are some questions with low reliability 
due to limited true (underlying) variation between hospi-
tals. In such cases, it is very hard to distinguish between 
hospitals since they are all performing at a similar level. 
As a consequence, in the absence of very large sample 
sizes, the observed variability between hospitals will 
be dominated by chance. A particular example of this 
phenomenon occurs for questions whose performance 
is consistently high/low across hospitals. It is harder to 
distinguish hospitals when performance is close to 0% 
or 100%. Lastly, there are other questions with a small 
number of respondents as they are applicable to only 
subsets of patients. In brief, the key mechanisms leading 
to low reliability are small hospital-level respondent 
sample, limited variability between hospitals (including 
because of ceiling/flooring effects) and small survey-level 
respondent sample.
Given one of the main uses of CPES is to inform hospital 
level performance, one might suggest that in its current 
form, the survey is not fit for one of its main intended 
purposes (though it should be noted that the reliability 
limitations we report do not affect the use of the survey 
for providing national-level intelligence about the experi-
ence of patients with cancer across English hospitals). It 
could be argued that rather than suppressing score made 
on the basis of less than 20 respondents as is currently 
done, all scores which have a reliability below 0.7 should 
be suppressed. Work in other contexts have shown that 
when reliability of metrics is low, there is a large amount 
of misclassification of performance.23 27 At the very least, 
we believe that users of the survey results should be made 
aware of the reliability of the hospital scores (with such 
reliability estimates accompanying the publicly reported 
scores) so that an informed interpretation can be made 
by patients, clinicians, managers and members of the 
public. There is a range of reasons why such transparent 
reporting of reliability of hospital scores may be useful. 
For example, a hospital may chose to focus improvement 
efforts on those questions where they perform worse than 
average and where they know their scores to be reliable. 
As we already noted, hospital comparisons are not the 
only purpose of the CPES. National assessments of patient 
experiences are supported by CPES and these data have 
been used to investigate variation and disparities in care 
between patient groups.24 25 For these uses that do not 
involve organisational comparisons, concerns about the 
lack of interunit reliability are not applicable. Further-
more, it can also be useful to know that all hospitals are 
performing above a target level even though we may not 
be able to distinguish between them.
There are various ways in which the survey could be 
changed in response to these findings. First, by redesigning 
the survey instrument or related reporting conventions. For 
example, questions where the variability between hospitals 
is very low could be considered as candidates for removal 
from subsequent survey waves as there is little point in clas-
sifying hospitals on aspects of care for which they have no 
tangible differences between them. A similar approach 
could be taken for questions where hospital performance 
is very high, although it may also be possible to add to or 
redesign the response options (or associated reporting 
conventions) to bring the mean reported scores closer to 
50%, which will increase the reliability of these items. We 
do note that in both these situations, there is something 
to be celebrated as a lack of variability suggests equitable 
healthcare delivery and in the context of ‘ceiling’ effects, a 
high performance implies high-quality healthcare delivery. 
However, continued measurement of such aspects may not 
be the best use of patient survey resources. It is not without 
irony that the aims of quality improvement efforts under-
pinned by patient surveys are to improve service and reduce 
disparities, both of which reduce reliability and in turn 
reduce the usefulness of such survey items.
Another way by which reliability could be increased is 
to increase the sample size. Currently, the CPES sample 
consists of all patients treated in a particular 3-month 
period. If a whole year sample was used instead, we would 
have up to four times as many patients available. Our find-
ings suggest that the vast majority of hospital-level scores 
in such a case would be reliable, though of course there 
would be an increase in cost of delivering the survey. 
Rather than continuing with the current ‘census’ approach 
(whereby all patients who fit eligibility criteria during the 
survey sampling period form part of the sampling frame), 
probability sampling could be used. This would mean 
surveying more patients than is currently done in hospitals 
treating small numbers of patients with cancer and fewer 
than currently done in those treating many patients with 
cancer, potentially having little impact on the total sample 
size. Indeed, the optimal design for a survey that puts equal 
importance on every hospital is an equal sample size for 
each hospital and fixed target respondent numbers per 
unit of assessment are already used in a number of NHS 
and international surveys.6 7 However, changing the length 
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of the sampling window will likely impact the composition 
of responders as this is dictated by variation in treatment 
modalities, early mortality and non-response, the effect of 
which will depend on the sampling window.28 This in turn 
may impact the ability to compare results to those from 
previous years. An alternative approach of aggregating 
multiple years of survey results will also improve reliability, 
though it will reduce the timeliness of scores and poten-
tially reduce the usability of the findings. Similarly, improve-
ments in response rate can also increase the sample size, in 
turn improving reliability. The scope for improvement in 
this survey may be limited due to it already having a high 
response rate, but for other surveys that may not be true.
COnClusIOn
The English Patient Experience Survey represents a 
globally unique source for understanding experience of 
a patient with cancer; but in its present form, it is not 
reliable for high stakes comparisons of the performance 
of different hospitals. In profiling the survey, we have 
found that around two-thirds of hospital scores are not 
reliable. This severely hampers the use of this survey for 
hospital comparisons and raises questions over the suit-
ability of its current design. Classifying hospitals as being 
a poor performer on an unreliable question may lead to 
unfair reputational loss and misplaced quality improve-
ment efforts resulting in an opportunity cost. Classifying 
hospitals as high performers on unreliable questions may 
lead to false reassurance in related areas thus missing the 
opportunity for improvement. Redesigning the questions 
and sampling strategy used could dramatically improve 
the percentage of reliable hospital scores and thus making 
the survey far more useful.
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